[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.140.188. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
January 5, 2011

Terminology for Preparations of Botulinum NeurotoxinsWhat a Difference a Name Makes

Author Affiliations

Author Affiliation: Istituto Neurologico Carlo Besta, Università Cattolica del Sacro Cuore, Milano, Italy.

JAMA. 2011;305(1):89-90. doi:10.1001/jama.2010.1937

The market for botulinum neurotoxins is becoming as crowded in the United States as in Europe. Last year, following approval of a second type A botulinum neurotoxins, the US Food and Drug Administration announced generic (or nonproprietary) name changes for all of the versions of injectable botulinum neurotoxins, and added a boxed warning on the labels of these potential biological weapons to describe the spread of the toxin and the attendant, possibly life-threatening effects.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×